Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Vascular endothelial growth factor variants

Vascular endothelial growth factor variants

US Patent 6475796 · Granted Nov 5, 2002

Estimated economic value: $8,913,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Use of NRG4, or inhibitors thereof, in the treatment of colon and pancreatic can2009
Use of NRG4, or inhibitors thereof, in the treatment of colon and pancreatic can2007
Recombinant fibroblast growth factor analogs2007
Vascular endothelial growth factor variants2005
Vascular endothelial growth factor variants2005
Nucleic acids sequence, stress-induced proteins and uses thereof2001
Method for producing a peptide with a pI above 8 or below 52001
Human basic fibroblast growth factor analog2001
Heparin binding mitogen with homology to epidermal growth factor (EGF)2001
Human basic fibroblast growth factor analog1999
Heparin binding mitogen with homology to epidermal growth factor (EGF)1998
Nucleic acids sequence, stress-induced proteins and uses thereof1998